Western blot analysis showed that GADD34 heterozygous mutation did not change p-eIF2α level, modestly elevated ATF4 level, and moderately increased CHOP level in medulloblastoma in Ptch1+/− mice (Figure 2C, 2D). This evidence concerns the gene EIF2A and medulloblastoma.